(Q41525992)

2 October 2017

1 reference

title

Emerging treatments for rheumatoid arthritis (English)

1 reference

2 October 2017

M Schiff

1

1 reference

2 October 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

American Journal of Medicine

2 October 2017

published in

1 reference

2 October 2017

volume

102

1 reference

2 October 2017

issue

1A

1 reference

2 October 2017

page(s)

11S-15S

1 reference

The importance of age, education, and comorbidity in the substantial earnings losses of individuals with symmetric polyarthritis

2 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900411-7

The work dynamics of the person with rheumatoid arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900411-7

Prognosis of functional capacity and work capacity in rheumatoid arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900411-7

The antiquity of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900411-7

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900411-7

Prevalence of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900411-7

Rheumatoid arthritis. Pathophysiology and implications for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900411-7

Interleukin-6 in relation to other proinflammatory cytokines, chemotactic activity and neutrophil activation in rheumatoid synovial fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900411-7

Association of the B-cell alloantigen DRw4 with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900411-7

Does Drug Therapy Slow Radiographic Deterioration in Rheumatoid Arthritis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900411-7

Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900411-7

Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900411-7

Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900411-7

Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900411-7

Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900411-7

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900411-7

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900411-7

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900411-7

Advances in immunotherapy of rheumatoid arthritis: clinical and immunological findings following treatment with anti-CD4 antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900411-7

Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2897%2900411-7

10.1016/S0002-9343(97)00411-7

7 January 2021

Identifiers

DOI

1 reference

2 October 2017

1 reference